ReviewFrontiers in neurology
Collateral circulation after revascularization in moyamoya disease: influencing factors and underlying mechanisms.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral revascularization is a primary treatment for moyamoya disease and is generally considered to improve cerebral perfusion while potentially reducing the risk of stroke recurrence. However, the efficiency of postoperative collateral circulation formation varies significantly among individuals, and some patients continue to experience adverse events, such as recurrent ischemia or cerebral hemorrhage, which may be related to inadequate collateralization. Therefore, identifying the factors influencing the formation of collateral circulation after cerebral revascularization is critical for the treatment of moyamoya disease. Previous studies suggest that multiple factors are associated with postoperative collateral vessel formation, including genetic susceptibility (such as the RNF213 p. R4810K variant and microRNA regulation), angiogenic growth factors (such as VEGF, PDGF, and TGF-β1), soluble receptors (e.g., sTie-2), cellular components (including circulating endothelial progenitor cells and mesenchymal stem cells), structural regulators such as Caveolin-1, as well as clinical variables including surgical modality, patient age, and superficial temporal artery blood flow. This article systematically reviews current evidence on factors associated with collateral circulation formation after cerebral revascularization in patients with moyamoya disease, with the aim of informing future research and optimizing treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.